Related Experiment Video
Updated: Jan 18, 2026

10:05
A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
Published on: March 18, 2021
7.5K
Sustained inhibitory dysfunction in complement component C1qa-deficient mice underlies epilepsy and comorbidities.
Joseane Righes Marafiga1, Thy Vu1, Jessica Bowlus1
1Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, United States.
Progress in Neurobiology
|January 16, 2026
Summary
Complement component C1qa (C1qa) deficiency disrupts inhibitory neurons, leading to brain circuit dysfunction, anxiety, and seizures. Restoring interneurons improved behavior but not seizures, indicating complex C1qa roles.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Neuronal network refinement is crucial for brain function.
- Complement component C1qa (C1qa) dysregulation is linked to neurological disorders, primarily affecting excitatory synapses.
- The role of C1qa in inhibitory circuits is poorly understood.
Purpose of the Study:
- Investigate the impact of C1qa downregulation on inhibitory circuits.
- Determine C1qa's role in somatostatin (SST)-expressing interneurons in the somatosensory cortex.
- Elucidate C1qa's contribution to neurological dysfunction and absence seizures.
Main Methods:
- Germline deletion of C1qa in a mouse model.
- Analysis of layer 6 SST interneurons in the somatosensory cortex.
- Electrophysiological recordings to assess synaptic transmission and network activity.
- Behavioral tests for anxiety and sensory-driven responses.
- Transplantation of medial ganglionic eminence (MGE)-derived interneuron precursors.
Main Results:
- C1qa deletion disrupts layer 6 SST interneurons.
- This disruption leads to enhanced excitatory synaptic transmission and electrographic spike-and-wave discharges.
- Mice exhibited anxiety-like behavior and impaired sensory-driven behavior.
- Interneuron precursor transplantation rescued behavioral deficits but not the seizure phenotype.
Conclusions:
- C1qa is critical for maintaining inhibitory network integrity.
- C1qa downregulation contributes to neurological disorders through interneuron dysfunction.
- Additional mechanisms beyond interneuron dysfunction are involved in absence seizure pathophysiology.
Related Concept Videos
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K

